NCT03624946View on ClinicalTrials.gov

Study in Healthy Volunteers Evaluating Safety and Pharmacokinetics of Zika Virus Immune Globulin (ZIKV-IG)

PHASE1CompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

June 27, 2018

Primary Completion Date

March 6, 2019

Study Completion Date

March 6, 2019

Conditions
Zika Virus InfectionZika Virus Disease
Interventions
BIOLOGICAL

Zika Virus Immune Globulin (ZIKV-IG)

Zika Virus Immune Globulin (ZIKV-IG) is a human immune globulin preparation containing neutralizing antibodies to Zika virus.

OTHER

Placebo

Placebo is a normal saline solution (0.9% sodium chloride).

Trial Locations (1)

M5V 2T3

Syneos Health, Early Phase, Toronto

Sponsors
All Listed Sponsors
lead

Emergent BioSolutions

INDUSTRY